10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:142
Name:Compound 142
Description:Original numeration in publication: 6i
Labels:Training_set, Phthalazines
CAS:
InChi Code:InChI=1S/C28H21N5O2/c34-23-16-10-19(11-17-23)18-29-33-28(35)21-12-14-22(15-13-21)30-27-25-9-5-4-8-24(25)26(31-32-27)20-6-2-1-3-7-20/h1-18,34H,(H,30,32)(H,33,35)/b29-18+

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.44

El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278

6.28226

Eq1: VEGFR-2 inhibition (Data used to train model)